Certain tetrahydrocannabinol-7-oic acid derivatives
Patent 5538993 Issued on July 23, 1996. Estimated Expiration Date: 
February 7, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 7, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesNovel tetrahydrocannabinol type compounds Delta 1-thc-7-oic acid and analgesic and anti-inflammatory agents (3S-4S)-7-hydroxy-Ɗ6 -tetrahydrocannabinols Deuterated cannabinoids as standards for the analysis of tetrahydrocannabinol and its metabolites in biological fluids Fluorescene polarization immunoassay for tetrahydrocannabinoids Patent #: 5144030 InventorsAssigneeApplicationNo. 192923 filed on 02/07/1994US Classes:514/454, Tricyclo ring system having the hetero ring as one of the cyclos549/390Dibenzo(b,d)pyrans (including hydrogenated)ExaminersPrimary: Richter, JohannAssistant: Peabody, John Attorney, Agent or FirmInternational ClassesA61K 031/35C07D 311/80 Foreign Application Priority Data1991-09-14 ILAbstractThe invention relates to compounds of the formula ##STR1## having the (3S,4S) configuration and being essentially free of the (3R,4R) enantiomer, in which A--B indicates an optional 1(2) or 6(1) double bond, X is carboxy, carbalkoxy, or carboxamido, linked to the ring directly or through an alkylene linkage, G is halogen, alkyl, or oxy, and Y is alkyl, oxy, or oxyalkylene. The invention further relates to the synthesis of such compounds, and to pharmaceutical compositions and therapeutic methods in which such compounds may be employed.Other References
|
| ||||||||||||||
